- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Drug products patented sales in Canada by therapeutic class 2017
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Drug products patented sales in Canada by therapeutic class 2017
Patented drug products sales in Canada in 2017, by therapeutic class (in million Canadian dollars)*
by Matej Mikulic,
last edited
Aug 29, 2018
This statistic displays the sales of patented drug products in Canada in 2017, sorted by therapeutic class. Antineoplastics and immunomodulating agents generated around 5.72 billion Canadian dollars of revenue.
Patented drug products sales in Canada in 2017, by therapeutic class (in million Canadian dollars)*
| Sales in million Canadian dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Sales in million Canadian dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Aug 29, 2018
This statistic displays the sales of patented drug products in Canada in 2017, sorted by therapeutic class. Antineoplastics and immunomodulating agents generated around 5.72 billion Canadian dollars of revenue.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- July 2018
- Region
- Canada
- Survey time period
- 2017
- Supplementary notes
- * These groups have been combined for reasons of confidentiality.
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- July 2018
More information
- Region
- Canada
- Survey time period
- 2017
- Supplementary notes
- * These groups have been combined for reasons of confidentiality.
Other statistics on the topic
+Pharmaceutical Products & Market
Research and development in European pharmaceutical industry by country 2017
+Pharmaceutical Products & Market
VAT rate on prescription-only drugs in Europe 2018
+Pharmaceutical Products & Market
Leading 18 European pharmaceutical companies by retail sales 2015
Pharmaceutical Products & Market
Market share of generics in European countries 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2015
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)Leading European pharmaceutical & biotechnology companies ranked by market value 2015
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)Leading European pharmaceutical companies by R&D spending 2015
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)Leading European pharmaceutical companies by R&D investment 2014
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2018
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2017Employment in European pharmaceutical industry by country 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018Employment in EFPIA pharmaceutical industry 1990-2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018Number of employees in the pharmaceutical industry in Italy 2000-2018
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Patented drug products annual sales change in Canada 1991-2017
- Drug products patented sales share in Canada, by therapeutic class 2017
- Canadian drug market sales contribution of patented drugs 1990-2017
- New NASs reviewed by medicine prices review board Canada 2011-2016 by improvement
- Patent drug sales impact on change in expenditure by therapy class in Canada 2017
- Average price ratio of patented drugs in Canada 2017 and year of introduction
- Total patented drugs for human use in Canada in 2017 by introduction time
- New drugs patented for human use distribution in Canada 1989-2017
- Patented drug 2017 sales share distribution by year of product introduction
- Sales growth changes of patented drugs in Canada 2017
- Pharmaceutical sales in Canada 2004-2017
- Quantity change of patented drugs in Canada by therapy class 2015-2016
- Rate of price change for patented drugs 2017, by country
- Patented drug products annual sales in Canada 1990-2017
- Patented drug product international prices compared to prices in Canada 2004-2017
- Annual testosterone drug revenue in the United States 2013 and 2018
- Inter partes reexamination filings in the U.S. 2007-2012, by discipline
- Newly granted patents in China 2017
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018
- Market share of generics in selected European countries as of 2017
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Patented drug products annual sales change in Canada from 1991 to 2017
- Patented drug products sales share in Canada 2017, by therapeutic class
- Patented drugs sales contribution in total Canadian drug market from 1990 to 2017
- Number of new active substances (NASs) reviewed by PMPRB Canada from 2011 to 2016, by therapeutic improvement*
- Patented drug sales impact on changes in expenditure in Canada by therapeutic class in 2017
- Average patented drugs ratio in Canada of 2017 price to introduction price
- Total number of patented drugs for human use in Canada in 2017, by time of introduction
- Distribution of new patented drug in Canada for human use from 1989 to 2017
- Distribution of Canada's patented drug sales generated in 2017, by year of product introduction
- Patented drugs sales changes in Canada during 2017 (in million Canadian dollars)
- Total pharmaceutical sales in Canada from 2004 to 2017 (in billion Canadian dollars)
- Patented drugs quantity changes in Canada between 2015 and 2016, by therapeutic class*
- Patented drugs average price change in 2017, by country
- Patented drug product sales in Canada from 1990 to 2017 (in billion Canadian dollars)
- Average ratio of median international prices to Canadian prices for patented drugs from 2004 to 2017*
- Annual testosterone drug revenue in the U.S. in 2013 and 2018 (in billion U.S. dollars)
- Number of inter partes reexamination filings in the United States from 2007 to 2012, by discipline
- Number of newly granted patents in China from 2007 to 2017 (in thousands)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.